Mutations in the APP gene are popularly known as the second cause trigger the familial Alzheimer's disease (AD). We generated a human induced pluripotent stem cell (iPSC) line from the peripheral blood mononuclear cells isolated from an AD patient using non-integrative Sendai virus. The iPSC line highly expresses pluripotency markers, has the capacity to differentiate into the normal teratoma tissue, retains the APP mutation, and displays the normal karyotype. The iPSC line will provide a useful resource to study the pathogenesis and drugs screening of AD.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.scr.2022.102690 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!